MAA
TRIB

Managed Account Advisors’s Trinity Biotech TRIB Stock Holding History

Managed Account Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Hold
0
– – – 2786
2014
Q3 		– Sell
-5
Closed -$16.2K – 2723
2014
Q2 		$17K Hold
5
– – ﹤0.01% 2530
2014
Q1 		$18K Buy
+5
New +$19.7K ﹤0.01% 2485

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Managed Account Advisors's TRIB Position: Q4 2014 in Review

Managed Account Advisors held its Trinity Biotech (TRIB) position steady in Q4 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Managed Account Advisors first reported a position in TRIB in Q1 2014 and has held it in 2 quarters since. The position peaked at $18K in Q1 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Managed Account Advisors held 0 shares of Trinity Biotech worth $0 as of Q4 2014.
  • Managed Account Advisors left its Trinity Biotech share count unchanged in Q4 2014.
  • Trinity Biotech made up ﹤0.01% of Managed Account Advisors's portfolio in Q4 2014, its #2786 holding.
  • Managed Account Advisors first reported a position in Trinity Biotech in Q1 2014 and has held it in 2 quarters since.
  • Managed Account Advisors's Trinity Biotech position peaked at $18K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.